Press releases

All press releases Regulatory

Regulatory press release 2025-07-11

XSpray Pharma achieves significant milestone – demonstrating bioequivalence with absorption advantages compared to Tasigna

Regulatory press release 2025-06-27

Xspray Pharma Passes FDA Pre-Approval Inspection – Key Regulatory Milestone Achieved for Dasynoc

Regulatory press release 2025-05-14

FDA sets PDUFA-date for Xspray Pharma’s re-submitted application for Dasynoc®

Regulatory press release 2025-05-13

Bulletin from the annual general meeting of Xspray Pharma AB (publ)

Regulatory press release 2025-05-07

Interim Report First Quarter 2025

All press releases

Latest report
Interim Report Q1 2025
Subscribe
Get our latest press releases and reports
Subscribe
Submit to our press releases and get an email every time we publish a press release or report on our website.
Type*
Reports
Press releases
E-mail*

Välj språk*
Swedish
English
When clicked on Send I agree that my personal information will be saved. Read more
Email
This field is for validation purposes and should be left unchanged.

Press contact

Jacob Nyberg, IR

+46 70-767 08 83

info@xspray.com

Media